Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

Richter WJ et al. included 254 CF patients over the age of 18 in a retrospective cohort study to investigate whether vitamin D deficiency is a risk factor for NTM infection.

Source: 3. Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Review / evidence synthesis.

Review / evidence synthesis

Reviews existing research; the exact review methods need further assessment.

Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Publisher article type: review-article

Source: Publisher publication metadata.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

The Epidemiology of Nontuberculous Mycobacteria in Cystic Fibrosis

Review / evidence synthesis · Children · 2025

Original publication title

The Epidemiology of Nontuberculous Mycobacteria in Cystic Fibrosis

Aikaterini Sotiropoulou; Ioanna Loukou; Christiana Vliora; Konstantinos Douros; Maria Moustaki

© 2025 by the authors.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

Abstract: Highlights

What are the main findings?

  • NTM is a concern for patients with CF even in the era of CFTR modulators

  • The prevalence of NTM in CF patients varies considerably among studies making difficult to have a global estimation of the NTM burden in CF

What is the implication of the main finding?

  • Further multicenter prospective studies are needed to precisely assess the global burden of NTM in CF in the era of CFTR modulators

Source: Highlights Source: Highlights

Abstract: Abstract

Background: Nontuberculous mycobacteria (NTM) are opportunistic pathogens responsible for chronic pulmonary infections, primarily affecting individuals with underlying conditions such as cystic fibrosis (CF). The aim of this review is to present the epidemiological profile of NTM in CF patients, with a focus on incidence, prevalence, predominant species, and geographic distribution. Methods: The search included cross-sectional, retrospective, and prospective observational studies published in English that reported epidemiological data concerning the isolation and/or infection of individuals with CF by NTM. NTM infection was defined as the isolation of any NTM species at least once per patient.

Out of an initial 1120 references identified in PubMed, and following the application of exclusion criteria based on PRISMA guidelines, a total of 78 studies were included. Results: The reported prevalence of NTM in CF patients ranges globally from 0% to 40.9%. This wide variability is attributed to population heterogeneity, study period, and geographical region. Of the studies included, 30 were conducted in Europe and 25 in the U.S.A. Mycobacterium abscessus and the Mycobacterium avium complex (MAC) were the most commonly isolated species, with MAC being more prevalent in older individuals.

The incidence of NTM pulmonary disease was high, with the majority of cases being associated with M. abscessus. Although emerging evidence suggests that CFTR modulator therapy may reduce the risk of NTM isolation and/or disease, current data remain limited. Conclusions: Nontuberculous mycobacteria are significant pathogens in patients with cystic fibrosis, with a negative impact on respiratory health.

Source: Abstract
Authors’ abstract

Highlights

What are the main findings?

  • NTM is a concern for patients with CF even in the era of CFTR modulators

  • The prevalence of NTM in CF patients varies considerably among studies making difficult to have a global estimation of the NTM burden in CF

What is the implication of the main finding?

  • Further multicenter prospective studies are needed to precisely assess the global burden of NTM in CF in the era of CFTR modulators

Abstract

Background: Nontuberculous mycobacteria (NTM) are opportunistic pathogens responsible for chronic pulmonary infections, primarily affecting individuals with underlying conditions such as cystic fibrosis (CF). The aim of this review is to present the epidemiological profile of NTM in CF patients, with a focus on incidence, prevalence, predominant species, and geographic distribution. Methods: The search included cross-sectional, retrospective, and prospective observational studies published in English that reported epidemiological data concerning the isolation and/or infection of individuals with CF by NTM. NTM infection was defined as the isolation of any NTM species at least once per patient.

Out of an initial 1120 references identified in PubMed, and following the application of exclusion criteria based on PRISMA guidelines, a total of 78 studies were included. Results: The reported prevalence of NTM in CF patients ranges globally from 0% to 40.9%. This wide variability is attributed to population heterogeneity, study period, and geographical region. Of the studies included, 30 were conducted in Europe and 25 in the U.S.A. Mycobacterium abscessus and the Mycobacterium avium complex (MAC) were the most commonly isolated species, with MAC being more prevalent in older individuals.

The incidence of NTM pulmonary disease was high, with the majority of cases being associated with M. abscessus. Although emerging evidence suggests that CFTR modulator therapy may reduce the risk of NTM isolation and/or disease, current data remain limited. Conclusions: Nontuberculous mycobacteria are significant pathogens in patients with cystic fibrosis, with a negative impact on respiratory health.

Publication and source details

Original title: The Epidemiology of Nontuberculous Mycobacteria in Cystic Fibrosis

Aikaterini Sotiropoulou; Ioanna Loukou; Christiana Vliora; Konstantinos Douros; Maria Moustaki

Children · 2025

* Correspondence: mar.moustaki@gmail.com© 2025 by the authors.2025https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).The research received no external funding.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T02:50:51.868029+00:00

DOI: 10.3390/children12091270 · PMC12468492